secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K/A
Filed at:   2021-12-10T23:59:59+00:00
Accession:  0001654954-21-013049
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica files pro forma financials for Pulse Veterinary acquisition; $71.9M cash price
--------------------------------------------------------------------------------

- Preliminary purchase price of $71.9M funded from cash; pro forma cash after deal $197.7M.
- Pro forma 2020 net loss $13.4M, including $1.5M amortization on acquired intangibles.
- Acquired intangible assets valued at $33.65M with 11-19 year useful lives; goodwill $44.9M.
- Branford PVT generated $7.1M revenue in 2020 and $8.5M in 9mo 2021; combined entity net loss.
- Audited financial statements of Branford PVT filed as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495421013049/0001654954-21-013049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495421013049/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-013049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer